LOGIN 
 

JOIN
 

RENEW
 

CME/MOC

 

SEARCH

Pulmonary Fibrosis Week

Home ▶ Patients ▶ Lung Disease Week at the ATS ▶ 2020 ▶ Pulmonary Fibrosis Week ▶ Information for Experts


Information for Experts

pf 

Pulmonary Fibrosis Foundation Products

The Pulmonary Fibrosis Foundation’s (PFF) Patient Communication Center is a hub for information and resources for patients, families, and healthcare professionals. Call 844.TalkPFF (844.825.5733) or email pcc@pulmonaryfibrosis.org. We will ship our educational materials free of charge.

PFF Patient Registry
The PFF Patient Registry is a resource of data gathered from 2,000 patient volunteers across the country to help researchers further understand the disease and develop treatments.

PFF Care Center Network
The PFF’s Care Center Network is comprised of 60 medical centers nationwide offering comprehensive and individualized care to those living with PF.

PFF Research Funds
These funds support both junior and established investigator research projects.

Health Provider Educational Materials
The PFF provides digital and printed educational resources for healthcare providers including the Nursing and Allied Health Guide, the ILD Pocket Guide for physicians, and the Pulmonary Rehabilitation Pocket Guide for respiratory therapists and physical therapists. Hard copies of these materials are available for free through our Patient Communication Center.

CME/CE Library
Explore CME/CE activities relating to education about pulmonary fibrosis and ILD.

 

ATS Educational Products

INTERSTITIAL LUNG DISEASE: CURRENT TRENDS IN DIAGNOSIS AND MANAGEMENT

WHEN THERE IS NO RIGHT ANSWER: A PRO/CON DEBATE ON CONTROVERSIES IN ILD

DISCOVERING THE ROLE OF STEM CELL FATE IN LUNG INJURY AND FIBROSIS

 

 

ClinicianATS Journals on Pulmonary Fibrosis

 

American Journal of Respiratory and Critical Care Medicine

Lung Development Genes and Adult Lung Function
2020
Link to Abstract

Bronchoalveolar Lavage is Safe and Well Tolerated in Individuals with Idiopathic Pulmonary Fibrosis: An Analysis of the PROFILE Study
2020
Link to Abstract

Update in Interstitial Lung Disease 2019
2020
Link to Abstract

The Bloom is in Bud for Interstitial Lung Diseases
2020
Link to Abstract

The Lung Microbiome in Health, HP and IPF: A Heavy Bacterial Burden to Bear
2020
Link to Abstract

Molecular Imaging of Pulmonary Fibrosis: Another Step Forward
2020
Link to Abstract

Preclinical Pulmonary Fibrosis (PrePF) Circulating Protein Biomarkers
2020
Link to Abstract

Patient-reported Outcomes for Clinical Trials in Idiopathic Pulmonary Fibrosis: New Opportunities to Understand How Patients Feel and Function
2020
Link to Abstract

Home Monitoring in Patients with Idiopathic Pulmonary Fibrosis. A Randomized Controlled Trial
2020
Link to Abstract

The Respiratory Microbiome in Chronic Hypersensitivity Pneumonitis is Distinct from that of Idiopathic Pulmonary Fibrosis
2020
Link to Abstract

Chemokine Receptor 2-targeted Molecular Imaging in Pulmonary Fibrosis
2020
Link to Abstract

Development and Initial Validation Analyses of the Living with Idiopathic Pulmonary Fibrosis (L-IPF) Questionnaire
2020
Link to Abstract

Interstitial Lung Disease in Relatives of Patients with Pulmonary Fibrosis
2020
Link to Abstract

Diaphragmatic Atrophy May Limit Progression of Idiopathic Pulmonary Fibrosis
2020
Link to Abstract

Thrombomodulin Alfa for Acute Exacerbation of Idiopathic Pulmonary Fibrosis. A Randomized, Double-Blind Placebo-controlled Trial
2020
Link to Abstract

Genome-Wide Association Study of Susceptibility to Idiopathic Pulmonary Fibrosis
2019
Link to Abstract

 

 

American Journal of Respiratory Cell and Molecular Biology

PAD4 Deficiency Improves Bleomycin-induced Neutrophil Extracellular Traps and Fibrosis in Mouse Lung
2020
Link to Abstract

Blockade of Pan-Fibroblast Growth Factor Receptors Mediates Bidirectional Effects in Lung Fibrosis
2020
Link to Abstract

N-Glycosylation Regulates Chitinase 3–like-1 and IL-13 Ligand Binding to IL-13 Receptor α2
2020
Link to Abstract

Extracellular Vesicles: Bidirectional Accelerators of Cellular Senescence in Fibrosis?
2020
Link to Abstract

CD70 Activation Decreases Pulmonary Fibroblast Production of Extracellular Matrix Proteins
2020
Link to Abstract

Extracellular Vesicles from Fibroblasts Induce Epithelial Cell Senescence in Pulmonary Fibrosis
2020
Link to Abstract

Lost in Translation: ER-mitochondria Crosstalk in Idiopathic Pulmonary Fibrosis
2020
Link to Abstract

You Say You Want a Resolution (of Fibrosis)
2020
Link to Abstract

Active mTOR in Lung Epithelium Promotes Epithelial–Mesenchymal Transition and Enhances Lung Fibrosis
2020
Link to Abstract

Impaired Myofibroblast Dedifferentiation Contributes to Nonresolving Fibrosis in Aging
2020
Link to Abstract

Diverse Injury Pathways Induce Alveolar Epithelial Cell CCL2/12, Which Promotes Lung Fibrosis
2020
Link to Abstract

Long Noncoding RNA FENDRR Exhibits Antifibrotic Activity in Pulmonary Fibrosis
2020
Link to Abstract

Screening for YAP Inhibitors Identifies Statins as Modulators of Fibrosis
2020
Link to Abstract

Bleomycin Induces Drug Efflux in Lungs. A Pitfall for Pharmacological Studies of Pulmonary Fibrosis
2019
Link to Abstract

The Role of KCNMB1 and BK Channels in Myofibroblast Differentiation and Pulmonary Fibrosis
2019
Link to Abstract

Cross-Talk between Transforming Growth Factor-β and Periostin Can Be Targeted for Pulmonary Fibrosis
2019
Link to Abstract

Palmitic Acid–Rich High-Fat Diet Exacerbates Experimental Pulmonary Fibrosis by Modulating Endoplasmic Reticulum Stress
2019
Link to Abstract

The Oncogene ECT2 Contributes to a Hyperplastic, Proliferative Lung Epithelial Cell Phenotype in Idiopathic Pulmonary Fibrosis
2019
Link to Abstract

Overexpression of TIM-3 in Macrophages Aggravates Pathogenesis of Pulmonary Fibrosis in Mice
2019
Link to Abstract

 

 

Annals of ATS

Checking Siblings of Idiopathic Pulmonary Fibrosis Patients as a Scheme for Early Disease Detection
2020
Link to Abstract

Costs of Workplace Productivity Loss in Patients with Connective Tissue Disease–associated Interstitial Lung Disease
2020
Link to Abstract

The Pulmonary Fibrosis Foundation Patient Registry: Rationale, Design, and Methods
2020
Link to Abstract

Diagnostic Features in Combined Pulmonary Fibrosis and Emphysema (CPFE): A Systematic Review
2020
Link to Abstract

Associations between Patient-reported Outcomes and Death or Lung Transplant in Idiopathic Pulmonary Fibrosis. Data from the Idiopathic Pulmonary Fibrosis Prospective Outcomes Registry
2020
Link to Abstract

Health Care Costs at the End of Life for Patients with Idiopathic Pulmonary Fibrosis. Evaluation of a Pilot Multidisciplinary Collaborative Interstitial Lung Disease Clinic
2020
Link to Abstract

Pulmonary Pathology Society Perspective on the 2018 American Thoracic Society, European Respiratory Society, Japanese Respiratory Society, and Latin American Thoracic Society Idiopathic Pulmonary Fibrosis Clinical Practice Guidelines
2020
Link to Abstract

Idiopathic Pulmonary Fibrosis and Lung Cancer. A Systematic Review and Meta-analysis
2019
Link to Abstract

Outcomes of Older Patients with Pulmonary Fibrosis and Non–Small Cell Lung Cancer
2019
Link to Abstract

Idiopathic Pulmonary Fibrosis Guideline Recommendations. Need for Adherence to Institute of Medicine Methodology?
2019
Link to Abstract

YouTube Videos as a Source of Misinformation on Idiopathic Pulmonary Fibrosis
2019
Link to Abstract

Increased Airway Wall Thickness in Interstitial Lung Abnormalities and Idiopathic Pulmonary Fibrosis
2019
Link to Abstract

 

 

ClinicianATS Statements, Guidelines and Reports

 

Diagnosis of IPF: An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline Implementation Tools